McCulloch MK, Mehryab F, Rashnonejad A

Navigating the Landscape of CMT1B: Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches.

Int J Mol Sci 25:ijms25179227 (2024)
DOI:10.3390/ijms25179227

Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F

Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene.

Neurology 50:1397-401 (1998)
DOI:10.1212/wnl.50.5.1397

De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C

The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype.

Brain 122 ( Pt 2):281-90 (1999)
DOI:10.1093/brain/122.2.281

Mastaglia FL, Nowak KJ, Stell R, Phillips BA, Edmondston JE, Dorosz SM, Wilton SD, Hallmayer J, Kakulas BA, Laing NG

Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy.

J Neurol Neurosurg Psychiatry 67:174-9 (1999)
DOI:10.1136/jnnp.67.2.174

Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, Nicholson GA, Ouvrier RA, Tachi N

De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III).

Nat Genet 5:266-8 (1993)
DOI:10.1038/ng1193-266

Plante-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G

The Roussy-Levy family: from the original description to the gene.

Ann Neurol 46:770-3 (1999)
DOI:10.1002/1531-8249(199911)46:5<770::AID-ANA13>3.0.CO;2-U